HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Strumberg Selected Research

Cholesterol

2/2002Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Strumberg Research Topics

Disease

16Neoplasms (Cancer)
06/2019 - 10/2000
4Neoplasm Metastasis (Metastasis)
04/2016 - 05/2006
4Colorectal Neoplasms (Colorectal Cancer)
06/2013 - 01/2011
4Carcinoma (Carcinomatosis)
07/2008 - 06/2000
3Breast Neoplasms (Breast Cancer)
06/2019 - 02/2011
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2017 - 07/2010
2Adenocarcinoma
07/2012 - 07/2010
2Hypertension (High Blood Pressure)
02/2011 - 02/2002
2Peritoneal Neoplasms
07/2008 - 05/2006
1Triple Negative Breast Neoplasms
12/2014
1Cardiovascular Diseases (Cardiovascular Disease)
02/2011
1Mucositis
02/2011
1Diarrhea
02/2011
1Hyperlipidemias (Hyperlipidemia)
02/2011
1Thrombocytopenia (Thrombopenia)
02/2011
1Infections
02/2011
1Edema (Dropsy)
02/2011
1Leukopenia
02/2011
1Virus Diseases (Viral Diseases)
10/2010
1Alveolar Soft Part Sarcoma
07/2010
1Hepatocellular Carcinoma (Hepatoma)
03/2009
1Prostatic Neoplasms (Prostate Cancer)
12/2007
1Mesothelioma
05/2006
1Exanthema (Rash)
03/2006
1Lymphoma (Lymphomas)
03/2005
1Neurologic Manifestations (Neurological Manifestations)
03/2005
1Peripheral Nervous System Diseases (PNS Diseases)
03/2005
1Liver Neoplasms (Liver Cancer)
11/2004
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2004
1Second Primary Neoplasms (Neoplasms, Second)
02/2002
1Overweight
02/2002
1Testicular Neoplasms (Testicular Cancer)
02/2002
1Chromosome Breakage
02/2001
1Leukemia
02/2001

Drug/Important Bio-Agent (IBA)

10Sorafenib (BAY 43-9006)FDA Link
06/2019 - 12/2002
4Docetaxel (Taxotere)FDA Link
06/2019 - 07/2010
4Phosphotransferases (Kinase)IBA
06/2013 - 12/2002
4raf KinasesIBA
02/2012 - 12/2002
4Doxorubicin (Adriamycin)FDA LinkGeneric
03/2009 - 12/2003
3taxaneIBA
06/2019 - 02/2011
3Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2016 - 06/2008
3Fluorouracil (Carac)FDA LinkGeneric
06/2013 - 07/2010
3Cisplatin (Platino)FDA LinkGeneric
02/2012 - 02/2002
2nimotuzumabIBA
10/2017 - 07/2010
2ErbB Receptors (EGF Receptor)IBA
10/2017 - 07/2010
2GemcitabineFDA Link
10/2017 - 02/2012
2EverolimusFDA Link
12/2014 - 02/2011
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2014 - 02/2011
2Epirubicin (Ellence)FDA LinkGeneric
12/2014 - 02/2011
2Bevacizumab (Avastin)FDA Link
12/2014 - 02/2011
2AnthracyclinesIBA
12/2014 - 02/2011
2Irinotecan (Camptosar)FDA LinkGeneric
06/2013 - 01/2011
2regorafenibIBA
06/2013 - 05/2012
2Leucovorin (Folinic Acid)FDA Link
06/2013 - 01/2011
2Biomarkers (Surrogate Marker)IBA
01/2011 - 01/2011
2Sunitinib (Sutent)FDA Link
01/2011 - 01/2011
2Vincristine (Oncovin)FDA LinkGeneric
03/2005 - 03/2004
2Type I DNA Topoisomerases (Topoisomerase I)IBA
10/2000 - 06/2000
1Monoclonal AntibodiesIBA
10/2017
1AerosolsIBA
04/2016
1BI 2536IBA
07/2012
1Polo-Like Kinase 1IBA
07/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2012
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2012
1Lapatinib (GW572016)FDA Link
02/2011
1Growth Factor ReceptorsIBA
02/2011
1Trastuzumab (Herceptin)FDA Link
02/2011
1Paclitaxel (Taxol)FDA LinkGeneric
02/2011
1SU 12662IBA
01/2011
1plukenetione AIBA
10/2010
1nemorosoneIBA
10/2010
1Capecitabine (Xeloda)FDA Link
07/2010
1Cytostatic AgentsIBA
01/2010
1DNA AdductsIBA
06/2008
1Hormones (Hormone)IBA
12/2007
1Threonine (L-Threonine)FDA Link
05/2006
1tyrosine receptor (receptor, tyrosine)IBA
05/2006
1Serine (L-Serine)FDA Link
05/2006
1Oxygen (Dioxygen)IBA
11/2004
1SolutionsIBA
11/2004
120- O- (Nalpha- (4- (3- O- methylfucopyranosyloxy)phenylaminothiocarbonyl)histidylvalyl)camptothecinIBA
08/2004
1GlycoconjugatesIBA
08/2004
1CamptothecinIBA
08/2004
1Adrenocorticotropic Hormone (ACTH)FDA Link
03/2004
1Org 2766IBA
03/2004
1CholesterolIBA
02/2002
1Triglycerides (Triacylglycerol)IBA
02/2002
1Etoposide (VP 16)FDA LinkGeneric
02/2001
1Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2001
1Antineoplastic Agents (Antineoplastics)IBA
10/2000
1isoquinolineIBA
10/2000
1DNA (Deoxyribonucleic Acid)IBA
06/2000
1NucleotidesIBA
06/2000

Therapy/Procedure

6Drug Therapy (Chemotherapy)
06/2019 - 02/2002
5Therapeutics
06/2019 - 03/2005
3Neoadjuvant Therapy
12/2014 - 07/2010
1Combination Drug Therapy (Combination Chemotherapy)
05/2006
1Ligation
06/2000